AKT1 and neoplasm: AFP is involved in multidrug resistance (MDR) by activating the PI3K/AKT/mTOR signalling pathway, which leads to metabolic reprogramming of cancer stem cells, inhibition of the expression of apoptosis‐related enzymes and resistance to tumour cell apoptosis.13, 14, 15